Biogen Stocks Fall As They Tweak Their Research

 

The Biotechnology company Biogen is changing plans for their study on Alzheimer’s based on mid-study findings, making investors less confident. Based on their findings, 510 patients will need to be added to the final stage of the study. Biogen CMO Al Sandrock said, “ We did do a preplanned blinded sample size re-estimation. We did see more variability in the primary endpoint than assumed when we did the original sample size estimation, so we decided to increase the sample size to maintain 90% power. Therefore, we’re going to add 510 patients to the two studies.” With the recent changes and growing concerns for their stockholders, hopefully Biogens study will still pay off.

Follow us on social media for the latest updates in B2B!

Image

Latest

product
IPS Global Sales Meeting 2026: Jonathan Schavey on the Value of True Product Expertise at TekniPlex
April 9, 2026

In today’s fast-evolving industrial landscape, companies that thrive are those that combine technical mastery with deep institutional knowledge. Events like global sales meetings don’t just align strategy—they surface the expertise and perspective that often drive innovation behind the scenes. At TekniPlex, that depth is evident in the caliber of professionals shaping its product…

Read More
Connection
Rick McKenna Reflects on Timing, Connection, and Impact at the IPS Global Sales Meeting Mexico City 2026
April 9, 2026

Corporate gatherings often walk a fine line between urgency and reflection, but the most impactful ones create space for both—allowing ideas to breathe while still driving momentum. In a global organization like TekniPlex, where collaboration spans cultures and continents, the pacing and tone of meetings can shape not just outcomes, but relationships. This…

Read More
Learning
Exploring Cross-Regional Learning and Sales Innovation with Jeetendra Srivastava at IPS 2026 Mexico City
April 9, 2026

In an increasingly interconnected business landscape, global collaboration has shifted from being a strategic advantage to an operational necessity. Companies that foster cross-regional dialogue are often the ones that adapt fastest, borrowing insights from diverse markets and translating them into scalable success. Events like global sales meetings are no longer just corporate rituals—they…

Read More
leadership
A First Global Sales Meeting Experience: Divyesh Maru on Leadership, Learning, and Collaboration at IPS 2026
April 9, 2026

Global sales meetings are often framed as strategic checkpoints, but their real value lies in the human connections and shared understanding they foster across regions. In an increasingly complex business landscape, aligning finance, operations, and sales through firsthand experiences—like plant visits and product deep dives—can transform abstract goals into actionable insight. For companies…

Read More